Mesirow Financial Investment Management, Inc. Artivion, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.94 Billion
- Q3 2024
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Artivion, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 10,485 shares of AORT stock, worth $304,589. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,485Holding current value
$304,589% of portfolio
0.01%Shares
4 transactions
Others Institutions Holding AORT
# of Institutions
175Shares Held
36MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$81.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$81.2 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$79.8 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$71.2 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.17B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...